OssDsign

    OverviewSuggest Edit

    OssDsign is a medtech company dedicated to creating regenerative implants for improved healing of bone defects. The company provides neurosurgeons and reconstructive plastic surgeons with a range of implant solutions. Its products include OSSDSIGN Cranial, an implant solution for cranioplasty patients; OSSDSIGN Facial to treat complex facial skeletal defects; and OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage.
    TypePublic
    Founded2011
    HQUppsala, SEMap
    Websiteossdsign.com

    Recent NewsAll News

    Latest Updates

    Employees (est.) (Feb 2020)40
    Cybersecurity ratingAMore

    Key People/Management at OssDsign

    Anders Qvarnström

    Anders Qvarnström

    Director
    Simon Cartmell

    Simon Cartmell

    Director and Chairman
    Morten Henneveld

    Morten Henneveld

    CEO
    Newton Aguiar

    Newton Aguiar

    Director
    Anders Svensson

    Anders Svensson

    Interim CFO
    Henrik Hjort

    Henrik Hjort

    Director Marketing & Business Development
    Show more

    OssDsign Office Locations

    OssDsign has an office in Uppsala
    Uppsala, SE (HQ)
    Uppsala Business Park Rapsgatan 7 Postal Address:, Virdings allé 2
    Uppsala, SE
    Rapsgatan 23
    Show all (2)

    OssDsign Online and Social Media Presence

    OssDsign's Trends

    Embed Graph

    OssDsign News and Updates

    October 14, 2020

    Prestigious publication confirms potential of technology used by Karolinska Development's portfolio company OssDsign

    STOCKHOLM, SWEDEN – October 14, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that a scientific article describing the portfolio company OssDsign's unique regenerative implants has been published in the reputable scientific journal PNAS (Proceedings of the National Academy…
    September 18, 2020

    Karolinska Development’s portfolio company OssDsign strengthens patent coverage for OssDsign Cranial PSI in key market

    STOCKHOLM, SWEDEN – September 18, 2020. Karolinska Development (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has received a notice of allowance from the United States Patent and Trademarks Office (USPTO) concerning the implant design for the company’s product Cranial PSI, th…
    August 21, 2020

    Karolinska Development's portfolio company OssDsign reports positive interim results from a study in patients with bone defects in the oral cavity

    STOCKHOLM, SWEDEN – August 21, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the portfolio company OssDsign has presented positive interim results from a clinical study where its patented calcium phosphate material is used to restore bone defects in the oral cavity. T…
    June 01, 2020

    Karolinska Development’s portfolio company OssDsign recruits Morten Henneveld as new Chief Executive Officer

    STOCKHOLM, SWEDEN – June 1, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company OssDsign has appointed Morten Henneveld to the role of Chief Executive Officer. He takes up his new position on September 1, 2020, in conjunction with the retirement of the…

     OssDsign Frequently Asked Questions

    • When was OssDsign founded?

      OssDsign was founded in 2011.

    • Who are OssDsign key executives?

      OssDsign's key executives are Anders Qvarnström, Simon Cartmell and Morten Henneveld.

    • How many employees does OssDsign have?

      OssDsign has 40 employees.

    • Who are OssDsign competitors?

      Competitors of OssDsign include GreenBone Ortho, Tenex Health and BioIntegral Surgical.

    • Where is OssDsign headquarters?

      OssDsign headquarters is located at Uppsala Business Park Rapsgatan 7 Postal Address:, Virdings allé 2, Uppsala.

    • Where are OssDsign offices?

      OssDsign has an office in Uppsala.

    • How many offices does OssDsign have?

      OssDsign has 2 offices.